Calibre Scientific is pleased to announce that it has completed the acquisition of the NeXtal Biotechnologies line of structural biology products from Qiagen NV (NYSE: QGEN). NeXtal specializes in the production of unique screens and plates for protein crystallization, an important step in the complex process of structural biology studies and structure-based drug design. NeXtal’s products include a comprehensive suite of reliable crystallization screens and proprietary EasyXtal crystallization plates that are currently sold into academic, biotechnology, and pharmaceutical markets.
Read the full article: Calibre Scientific Acquires NeXtal Biotechnologies //
Source: https://www.globenewswire.com/news-release/2020/01/08/1967707/0/en/Calibre-Scientific-Acquires-NeXtal-Biotechnologies-to-Further-Expand-its-Protein-Portfolio.html